Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on
rolling-up annuity-based healthcare service companies in the US and Canada,
today announced it has finalized its proposed financing. Accommodating
oversubscriptions and US investor participation, the company has again increased
its total authorized placement from $2,540,000 to $2,740,000 and will close the
entire financing by September 1st, 2013.


Details of the Placement 

PHM has authorized a total placement of 20,269,269 common share units ("Units")
at a price of $0.135 per Unit for gross proceeds of $2,740,000. Each Unit
consists of one common share in the capital of PHM (a "Common Share") and
one-half of one common share purchase warrant (a "Warrant") of PHM. Each whole
Warrant entitles the holder thereof to acquire one Common Share at an exercise
price of $0.22 per Common Share up to the date that is the one year anniversary
of closing, and at a price of $0.28 per Common Share from the day after the one
year anniversary of closing until the two year anniversary of closing, subject
to acceleration. Compensation to placement agents consists of cash fees of 7% of
gross proceeds, plus warrants equal to 7% of the common stock issued at a strike
price of $0.135. All securities issued pursuant to the financing are subject to
a four-month hold period. 


About PHM

PHM is currently a positive cash flow and profitable company servicing patients
with chronic heart disease and will act as a platform for acquisitions. PHM is
focused on a highly fragmented and developing market of small privately-held
companies servicing chronically ill patients with multiple disease states caused
mainly by age and obesity. Because of the new and highly fragmented nature of
the market, PHM is actively working to identify and evaluate profitable,
annuity-based companies to acquire their patient databases and technical
expertise at favorable prices. PHM's post acquisition organic growth strategy is
to increase annual revenue per patient by offering multiple services to the same
patient, consolidating the patient's services and making life easier for the
patient. The expected result is growing EPS with each acquisition and growing
revenue and profits from the cross selling efforts. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
Stanmore Capital Partners, Inc.
Michael Dalsin
Chairman, Managing Director
(323) 253-3055

Patient Home Monitoring Corp. (TSXV:PHM)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Patient Home Monitoring Corp. Charts.
Patient Home Monitoring Corp. (TSXV:PHM)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Patient Home Monitoring Corp. Charts.